iiinova — where your digital self keeps evolving

Reposted by Sixten Harborg, MD

Breastcancer.org @breastcancerorg.bsky.social · 17/05/2025

At #ESMOBreast2025, @sixtenharborg.bsky.social shared a significant analysis from the Nurses’ Health Study showing that weight gain after diagnosis may raise #breastcancer death risk. Study followed 6,800+ women between 1978 - 2018, with follow-up ranging from 4–15 years. 🔗http://bit.ly/ESMO2025

021

Reposted by Sixten Harborg, MD

Journal of Internal Medicine @jinternmed.bsky.social · 31/01/2025

Follow the discussion! #Obesity treatment in #adolescents and adults in the era of personalized medicine ➡️The treatment arsenal has never been more diverse than now 🔹Review: doi.org/10.1111/joim.13816 🔹Regarding: doi.org/10.1111/joim.20063 🔹Authors reply: doi.org/10.1111/joim.20062

031

Sixten Harborg, MD @sixtenharborg.bsky.social · 08/01/2025

🚨PUBLISHED🚨 In an extensive effort to chart the impact of living with metabolic syndrome among BC survivors we conducted a large meta-analysis of >42,000 patients. We found that BC survivors living with metabolic syndrome had shorter DFS 📉 and increased risk of….

251

Reposted by Sixten Harborg, MD

Journal of Internal Medicine @jinternmed.bsky.social · 08/01/2025

Metabolic syndrome increases the risk for breast cancer events! 🚨 A meta-analysis reveals a 69% higher recurrence risk & 83% higher mortality risk in BC survivors with metabolic syndrome. ➡️ Is it time to prioritize metabolic health in BC care? 🔗 doi.org/10.1111/joim.20052 #bcsm #cancer

011

Reposted by Sixten Harborg, MD

Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 12/12/2024

It's a difficult topic to discuss- weight. Hugely personal, not easy to change, but impt. 4% ⬆️ recurrence in pts w/ node + #bcsm obese vs. lean 2% ⬆️ recurrence in pts with N0 dz 📌Magnitude of effect larger among premeno. 📌ER + AND ER neg @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social

0217

Sixten Harborg, MD @sixtenharborg.bsky.social · 12/12/2024

Beautifully depicted work on obesity and risk of distant recurrence in BC pts by EBCTCG👏🏻 Across data from 147 including 200.000+ pts they demonstrated that BMI is independently associated with risk of distant recurrence regardless of treatment characteristics📈 @sabcs.bsky.social

360

Sixten Harborg, MD @sixtenharborg.bsky.social · 12/12/2024

A great start to @sabcs.bsky.social day 3 with a session on survivorship. Intriguing data on GLP-1ra’s in adjuvant BC care❗️ As suspected by many GLP1ra’s seems to be less effective in pts treated with ET… Brilliantly discussed by @neil-iyengarmd.bsky.social 👏🏻

231

Sixten Harborg, MD @sixtenharborg.bsky.social · 12/12/2024

Happy to be @sabcs.bsky.social and share the results from our study on the risk of CVD events and CVD mortality in BC patients with type 2 diabetes 🫀📈 Thankful to @graspcancer.bsky.social for awarding our poster with the GRASP Advocate Choice Award🏅 If you are at #SABCS24 and would like to chat⬇️

281

Reposted by Sixten Harborg, MD

Eric Topol @erictopol.bsky.social · 27/11/2024

Lifestyle interventions to reduce cardiovascular and metabolic diseases, a new comprehensive review nature.com/articles/s41...

313929

Reposted by Sixten Harborg, MD

Johanna Joyce @johannajoyce.bsky.social · 23/11/2024

Both #Cancer #Research starter packs are now completely full! ~300 researchers, oncologists, students, postdocs, patient advocates, and organizations supporting cancer research 🧪🔬⚕️ I hope you'll find these useful to build our community here Pack 1: go.bsky.app/FEoaJMc Pack 2: go.bsky.app/6EcjWNA

3224388